Type 2 diabetes and cognitive dysfunction-towards effective management of both comorbidities

Publication date

2020-06

Authors

Srikanth, Velandai
Sinclair, Alan J
Hill-Briggs, Felicia
Moran, Chris
Biessels, Geert JanISNI 0000000117928938

Editors

Advisors

Supervisors

Document Type

Article

Collections

Open Access logo

License

taverne

Abstract

Type 2 diabetes and cognitive dysfunction are highly prevalent disorders worldwide. Although type 2 diabetes is associated with an increased risk of dementia, awareness of the link between the two conditions is poor, and few recommendations are available to guide clinicians about how to approach cognitive dysfunction in people with diabetes. Clinical guidelines in diabetes have only recently begun to emphasise the importance of cognitive impairment in diabetes and its management. This Series paper aims to synthesise knowledge about the link between diabetes and cognitive dysfunction, issues pertaining to screening and diagnosis of cognitive impairment and dementia in those with type 2 diabetes, management of diabetes in people with cognitive dysfunction (accounting for age and frailty), and emerging therapies for prevention. A conceptual framework for approaching screening and diagnosis is included, and future research directions to guide the field forward are suggested.

Keywords

Taverne, Endocrinology, Internal Medicine, Endocrinology, Diabetes and Metabolism, Review, Journal Article

Citation

Srikanth, V, Sinclair, A J, Hill-Briggs, F, Moran, C & Biessels, G J 2020, 'Type 2 diabetes and cognitive dysfunction-towards effective management of both comorbidities', The Lancet Diabetes & Endocrinology, vol. 8, no. 6, pp. 535-545. https://doi.org/10.1016/S2213-8587(20)30118-2